Literature DB >> 25769920

IgM and IgA rheumatoid factors purified from rheumatoid arthritis sera boost the Fc receptor- and complement-dependent effector functions of the disease-specific anti-citrullinated protein autoantibodies.

Florence Anquetil1, Cyril Clavel1, Géraldine Offer2, Guy Serre1, Mireille Sebbag3.   

Abstract

Rheumatoid factors (RF) and the disease-specific anti-citrullinated protein autoantibodies (ACPA) coexist in the joints of rheumatoid arthritis (RA) patients where they probably contribute to synovitis. We investigated the influence of IgM and IgA RF on the FcR- and complement-dependent effects of ACPA immune complexes (ACPA-IC). When stimulated by ACPA-IC formed in the presence of IgM RF or IgA RF fractions purified from RA serum pools, M-CSF-generated macrophages skewed their cytokine response toward inflammation, with increases in the TNF-α/IL-10 ratio and in IL-6 and IL-8 secretion, and decreases in the IL-1Ra/IL-1β ratio. In the IgM RF-mediated amplification of the inflammatory response of macrophages, the participation of an IgM receptor was excluded, notably by showing that they did not express any established receptor for IgM. Rather, this amplification depended on the IgM RF-mediated recruitment of more IgG into the ACPA-IC. However, the macrophages expressed FcαRI and blocking its interaction with IgA inhibited the IgA RF-mediated amplification of TNF-α secretion induced by ACPA-IC, showing its major implication in the effects of RF of the IgA class. LPS further amplified the TNF-α response of macrophages to RF-containing ACPA-IC. Lastly, the presence of IgM or IgA RF increased the capacity of ACPA-IC to activate the complement cascade. Therefore, specifically using autoantibodies from RA patients, the strong FcR-mediated or complement-dependent pathogenic potential of IC including both ACPA and IgM or IgA RF was established. Simultaneous FcR triggering by these RF-containing ACPA-IC and TLR4 ligation possibly makes a major contribution to RA synovitis.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25769920     DOI: 10.4049/jimmunol.1402334

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

Review 1.  Arthritis models: usefulness and interpretation.

Authors:  Natacha Bessis; Patrice Decker; Eric Assier; Luca Semerano; Marie-Christophe Boissier
Journal:  Semin Immunopathol       Date:  2017-03-27       Impact factor: 9.623

2.  Changes in anti-citrullinated protein antibody isotype levels in relation to disease activity and response to treatment in early rheumatoid arthritis.

Authors:  A Kastbom; K Roos Ljungberg; M Ziegelasch; J Wetterö; T Skogh; K Martinsson
Journal:  Clin Exp Immunol       Date:  2018-10-14       Impact factor: 4.330

Review 3.  Autoimmunity, inflammation, and dysbiosis mutually govern the transition from the preclinical to the clinical stage of rheumatoid arthritis.

Authors:  Alexander Kalinkovich; Gulzan Gabdulina; Gregory Livshits
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

4.  Mutations in Three Genes Encoding Proteins Involved in Hair Shaft Formation Cause Uncombable Hair Syndrome.

Authors:  F Buket Ü Basmanav; Laura Cau; Aylar Tafazzoli; Marie-Claire Méchin; Sabrina Wolf; Maria Teresa Romano; Frederic Valentin; Henning Wiegmann; Anne Huchenq; Rima Kandil; Natalie Garcia Bartels; Arzu Kilic; Susannah George; Damian J Ralser; Stefan Bergner; David J P Ferguson; Ana-Maria Oprisoreanu; Maria Wehner; Holger Thiele; Janine Altmüller; Peter Nürnberg; Daniel Swan; Darren Houniet; Aline Büchner; Lisa Weibel; Nicola Wagner; Ramon Grimalt; Anette Bygum; Guy Serre; Ulrike Blume-Peytavi; Eli Sprecher; Susanne Schoch; Vinzenz Oji; Henning Hamm; Paul Farrant; Michel Simon; Regina C Betz
Journal:  Am J Hum Genet       Date:  2016-11-17       Impact factor: 11.025

Review 5.  An Emerging Role for Neutrophil Extracellular Traps in IgA Vasculitis: A Mini-Review.

Authors:  Xiu-Qi Chen; Li Tu; Qing Tang; Li Huang; Yuan-Han Qin
Journal:  Front Immunol       Date:  2022-06-21       Impact factor: 8.786

Review 6.  Promising role of polymeric nanoparticles in the treatment of rheumatoid arthritis.

Authors:  Rida Siddique; Malik Hassan Mehmood; Muhammad Haris; Ammara Saleem; Zunera Chaudhry
Journal:  Inflammopharmacology       Date:  2022-05-07       Impact factor: 5.093

7.  In vitro eradication of citrullinated protein specific B-lymphocytes of rheumatoid arthritis patients by targeted bifunctional nanoparticles.

Authors:  Judit Pozsgay; Fruzsina Babos; Katalin Uray; Anna Magyar; Gergő Gyulai; Éva Kiss; György Nagy; Bernadette Rojkovich; Ferenc Hudecz; Gabriella Sármay
Journal:  Arthritis Res Ther       Date:  2016-01-16       Impact factor: 5.156

8.  Fc Gamma Receptors as Regulators of Bone Destruction in Inflammatory Arthritis.

Authors:  Yuyue Zuo; Guo-Min Deng
Journal:  Front Immunol       Date:  2021-06-23       Impact factor: 7.561

9.  In Rheumatoid Arthritis Patients, HLA-DRB1*04:01 and Rheumatoid Nodules Are Associated With ACPA to a Particular Fibrin Epitope.

Authors:  Guillaume Larid; Mikael Pancarte; Géraldine Offer; Cyril Clavel; Marielle Martin; Vincent Pradel; Isabelle Auger; Pierre Lafforgue; Jean Roudier; Guy Serre; Nathalie Balandraud
Journal:  Front Immunol       Date:  2021-06-24       Impact factor: 7.561

Review 10.  Therapeutic implications of autoantibodies in rheumatoid arthritis.

Authors:  Daniel Aletaha; Stephan Blüml
Journal:  RMD Open       Date:  2016-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.